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The phospholipid metabolism of rat peritoneal mast cells stimulated with mastoparan, a secretagogue puri- 
fied from wasp venom, was investigated. Mastoparan at 20 /rg/ml caused a rapid secretion of histamine. 
Mastoparan induced a transient decrease of phosphatidylinositol4,5-bisphosphate on J2P labeling and gene- 
ration of a water-soluble degradation product, inositol trisphosphate on [3H]inositol labeling, suggesting 
the activation of phospholipase C upon stimulation. 
Mast cell Phosphoinositide 
1. INTRODUCTION 
Rapid progress in understanding the mechanism 
of intracellular signal transduction has been made. 
When cell surface receptors are triggered, the 
signal is transduced to activate phospholipase C 
hydrolysis of PIP2, resulting in production of 2 
second messengers, DG and IP3. The former 
messenger stimulates protein kinase C and the lat- 
ter mobilizes intracellular Ca2+, both events 
leading to a variety of cellular responses including 
secretion, metabolism, phototransduction and cell 
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Calcium Mastoparan 
proliferation [l-3], As to mast cells, Katakami et 
al. [4] have reported the activation of protein 
kinase C in Con A-stimulated cells. Recently, 
several lines of evidence have indicated the involve- 
ment of GTP binding protein in regulating the 
phospholipase C activity of neutrophils [5] and 
mast cells [6,7]. 
Mastoparan is a tetradecapeptide purified from 
wasp venom and is known to be a potent 
secretagogue for histamine release from mast cells 
[8,9]. However, the underlying mechanism of 
secretion by this peptide has not yet been clarified. 
Since Higashijima et al. [lo] have demonstrated 
that mastoparan affects the physical state of mem- 
branes, it is postulated that this oligopeptide acts 
as a membrane-perturbing stimulant for mast cells. 
Argiolas and Pisano [9] have shown that this pep- 
tide induces arachidonic acid release in liposomes 
and rat mast cells, suggesting phospholipase A2 ac- 
tivation. However, there is no report regarding the 
effect of mastoparan on polyphosphoinositide 
metabolism mediated by phospholipase C. Here, 
we have investigated the phospholipid metabolism 
of mastoparan-stimulated cells, providing evidence 
which indicates that a membrane-perturbing 
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stimulation by mastoparan causes the hydrolysis of 
PIP& 
2. MATERIALS AND METHODS 
2.1. Isolation and radiolabeling of rat mast cells 
Mast cells were obtained from the peritoneal 
cavity of Wistar rats and purified through BSA 
gradient centrifugation as detailed [I 1 J. The 
viability of the cells was more than 90% as assessed 
by toluidine blue staining, Purified mast cells were 
prelabeled with ~3zP]orthophosphate (0.5 mCi/lO’ 
cells) for 60 min at 37°C. Radiolabeled cells were 
washed with MCM-EGTA to remove free label 
and resuspended in MCM containing 1.0 mM 
CaClz and 0.5 mM MgCl2. Polyethylene or 
siliconized glass was used in all experiments. 
2.2. Histamine reiease 
Mast cells (l-2 x lo5 cells/O.5 ml) were 
stimulated with the synthetic peptide, mastoparan. 
After the designated periods of time, histamine 
release was terminated by adding an equal volume 
of 10 mM EDTA-containing MCM 112). The con- 
tents of histamine in the supernatant and pellet 
were determined by the method of Shore et al. [13] 
using a Hitachi MPF-3 fluorescence spectrophoto- 
meter. 
2.3. Lipid metabolism 
Radiolabeled mast cells (3-5 x lo5 cells/OS ml) 
were stimulated by exposure to mastoparan at 
20 pug/ml for the indicated periods of time at 37°C. 
For phospholipid analyses, the reaction was 
terminated by the addition of 2 ml chloroform/ 
methanol (1: 2, v/v) and the lipids extracted by the 
method of Bligh and Dyer [14]. The polyphospho- 
inositides were extracted with 4 vols chloroform/ 
methanol/cone. HCl(20 : 40 : 1, v/v) and separated 
on HPTLC impregnated with 1% potassium 
oxalate using the system in [15]. Spots were iden- 
tified by comigration with authentic standards and 
radioautography was performed on X-Omat K5 
film. The areas corresponding to individual lipids 
were scraped into vials and the radioactivity deter- 
mined in a liquid scintillation counter (Beckman 
LS-7500) with toluene/Triton X-lOO/water/2,5di- 
phenyloxazole/2,2’ -p - phenylenebis(5 - phenylox - 
azole) (2800 ml/700 ml/175 ml/12 g/O.84 g) [16]. 
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2.4. Inositol ~~os~~ate analysis 
Mast cells were labeled with [3H]inositol 
(37.5 ,uCi/106 cells per 0.1 ml) in Hepes-buffered 
MCM for 2 h at 37°C under 5% COz/air [6]. After 
radiolabeling, the cells were further incubated in 
LiCl (10 mM to inhibit inositol-1-phosphatase) 
containing medium for 30 min at 37”C, then 
challenged with mastoparan (2O~g/ml) and the 
reaction was terminated by adding 3.76 vols 
chloroform/methanol/cone. HCl (50: 100 :1, v/v) 
[ 171. The aqueous phase was diluted with water, an 
aliquot of which was employed for total radioac- 
tivity counting and the rest was applied on an 
AG-1 x 8, 100-200 mesh, formate form column 
(0.6 x 4.0 cm) to elute free inositol. 
GlycerophosphoinositoI, IP, IP2 and IP3 were se- 
quentially eluted with 12 ml of 5 mM sodium 
tetraborate/60 mM ammonium formate, 16 ml of 
0.2 M ammonium formate/O. 1 M formic acid, 6 x 
4 ml of 0.4 M ammonium formate/O.l M formic 
acid, and 8 x 2 ml of 1.0 M ammonium for- 
mate/O.1 M formic acid, respectively. 2 ml of the 
IP3 fraction were first diluted with water to 4 ml, 
and the radioactivity in 4 ml of each fraction was 
counted in the gel phase using 60% (v/v) 
Aquasol- [ 171. 
2.5. ~ateriais 
[3H]Inositol was obtained from Amersham, and 
[32P]orthophosphate and Aquasol- were from 
New England Nuclear. Compound 48/80 and BSA 
(fraction V, essentially fatty acid free) were pur- 
chased from Sigma, the anion exchange resin 
AG-1 x 8 was from Bio-Rad, the HPTLC plates 
were Merck products and the X-Omat K5 film was 
a Kodak product. All other chemicals were of 
reagent grade. 
3. RESULTS AND DISCUSSION 
3.1. Histamine release from mastoparanstimu- 
lated mast cells 
Fig.lA shows a dose-response curve of 
mastoparan-triggered histamine release from mast 
cells after 5 min of incubation. The percent 
histamine release induced by 20 pg/ml mastoparan 
was 50% and reached 70% at 40 &g/ml. The time 
course of histamine release shown in fig. IB re- 
vealed that the secretory event is completed within 
5 s after the addition of mastoparan. A widely 
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Fig. 1. Mastoparan dose-dependent histamine secretion 
(A) and time course of histamine release (B). Rat 
peritoneal mast cells were exposed to the indicated 
concentrations of mastoparan for 5 min at 37°C (A), or 
to mastoparan at 20,~g/ml at 37°C for the designated 
periods of time (B). The release reaction was terminated 
by adding 2 vols of 10 mM EDTA-containing MCM, 
and the histamine content measured according to Shore 
et al. [13]. Results are expressed as the percentage of 
released histamine to the total cell-associated histamine. 
Each value is the mean of duplicate determination from 
a representative of 2 similar experiments. Bars indicate 
the range of 2 determinations. 
used secretagogue, compound 48/80 at 0.5 yg/ml, 
induced a slightly higher histamine release 
(60-70%) than mastoparan (not shown), but the 
time course of the secretory response was quite 
similar to that of mastoparan [16]. 
3.2. Polyphosphoinositide metabolism of masto- 
paran-stimulated mast cells 
When [32P]orthophoshate-labeled cells were 
stimulated with mastoparan (20 pg/ml), the total 
lipid-associated radioactivity progressively in- 
creased up to 140% of the control at 5 min after 
stimulation (not shown). The radioactivity of PA 
showed a progressive increase with incubation 
time. No significant changes in the radioactivity of 
PI were observed within 60 s following the addi- 
tion of the oligopeptide. PIP2 showed a transient 
decline of radioactivity at 10 s, followed by an 
abrupt and profound enhancement (fig.2). The 
PIP2 breakdown was also ascertained by the 
generation of IP3 in [3H]inositol-labeled cells in ac- 
cordance with the decrease in [32P]PIP2 (fig.3). 
PIP increased from 2.4 x lo4 to 3.5 x lo4 cpm at 
10 s, and did not show any further change in 
radioactivity within the time period examined 
(5 min). 
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Fig.2. Polyphosphoinositide metabolism in 
prelabeled mast cells triggered by mastoparan. __ 
=p_ 
Rat 
peritoneal mast cells, prelabeled with [‘LP]orthophos- 
phate, were incubated with 20pg/ml of mastoparan at 
37°C for the indicated times. Each value is the mean of 
duplicate determinations from a representative of 3 
similar experiments. Ranges refer to duplicate analysis. 
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Production of water-soluble inositol phosphates 
in mast cells stimulated with mastoparan. Rat peritoneal 
mast cells, prelabeled with [3H]inositol, were stimulated 
with mastoparan (20 pg/ml) for the indicated periods of 
time, and the reaction terminated by adding 3.76 vols 
chloroform/methanol/cone. HCl (50: lOO:l, v/v). 
Water-soluble inositol phosphates were separated by 
chromatography on anion exchange resin as described in 
section 2. Results are expressed as percentages of their 
respective control. The initial radioactivities at zero time 
for [3H]IP3, [3H]1P2 and [3H]IP were 98, 1350 and 2728, 
respectively. Ranges refer to duplicate analysis. 
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It has recently been reported that following 
receptor-ligand coupling, phospholipase C is ac- 
tivated to produce 2 putative second messengers, 
IP3 and DG, resulting in cellular responses. The 
former messenger enhances the level of in- 
tracellular free Ca*+ and the latter activates protein 
kinase C. However, the precise mechanism(s) re- 
mains to be clarified at the molecular level of ac- 
tivation of membrane phospholipid turnover. As 
an approach toward the understanding of this 
mechanism(s), we have attempted to analyze the 
activated phospholipid metabolism evoked by dif- 
ferent types of agonist in mast cells; (i) receptor- 
mediated (antigen), (ii) by-pass (PMA, iono- 
phore), and (iii) membrane-perturbing (compound 
48/80) stimulants. Mastoparan, acting as a se- 
cretagogue in mast cells, is known to be inter- 
calated into the lipid bilayer of liposomes [lo]. 
Although mastoparan directly interacts with the 
membrane, the presence of its receptor has not yet 
been defined. It is generally accepted that the by- 
pass stimulants, such as the Ca*+ ionophore 
A23187 and PMA, do not cause PIP2 hydrolysis. 
However, the data obtained here, that a 
membrane-perturbant (mastoparan) elicits the 
hydrolysis of PIP2 in response to its exposure, pro- 
vide evidence that the breakdown of PIP2 may not 
be specific for receptor-mediated cell stimulation. 
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